Range
672.54 - 685.66
Vol / Avg.
67.9K/127.1K
Div / Yield
-
52 Wk
472.84 - 689
Mkt Cap
20.3B
Payout Ratio
-
Open
676.91
P/E
5.03
EPS
32.77
Shares
29.8M
Outstanding
29.8M
Total Float
21.2M
load more
Sector: Health Care.Industry: Life Sciences Tools & Services
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (60% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the United States (40% of 2020 sales), Europe (34%), and Asia (21%), with Canada and Latin America accounting for the bulk of the remaining 5%. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS2.660

(EXPECTED) 2021-07-29

REV631.780M
Q1 2021Est.ActualSurprise
EPS3.0005.210 2.2100
REV660.980M726.796M65.816M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BIOBio-Rad Laboratories1.07%20.3B

Bio-Rad Laboratories Frequently Asked Questions

Q

How do I buy Bio-Rad Laboratories (BIO) stock?

A

You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bio-Rad Laboratories's (BIO) competitors?

Q

What is the target price for Bio-Rad Laboratories (BIO) stock?

A

The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Citigroup on February 12, 2021. The analyst firm set a price target for 750.00 expecting BIO to rise to within 12 months (a possible 9.87% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Bio-Rad Laboratories (BIO)?

A

The stock price for Bio-Rad Laboratories (NYSE: BIO) is $682.635 last updated Fri Jul 23 2021 19:59:41 GMT+0000 (Coordinated Universal Time).

Q

Does Bio-Rad Laboratories (BIO) pay a dividend?

A

There are no upcoming dividends for Bio-Rad Laboratories. The last dividend paid out to investors was $0.00 on Invalid DateTime.

Q

When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?

A
Bio-Rad Laboratories’s Q2 earnings are confirmed for after-market on July 29, 2021.
Q

Is Bio-Rad Laboratories (BIO) going to split?

A

There is no upcoming split for Bio-Rad Laboratories.

Q

What sector and industry does Bio-Rad Laboratories (BIO) operate in?

A

Bio-Rad Laboratories is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.